Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
305.90
-8.1 (-2.58%)
BSENSE

Dec 05

BSE+NSE Vol: 1.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
184.53
185.91
167.18
169.11
146.10
154.52
157.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
184.53
185.91
167.18
169.11
146.10
154.52
157.82
Raw Material Cost
48.74
43.97
45.94
36.76
39.05
40.20
35.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-4.18
6.08
0.15
2.07
-6.36
-5.95
-0.38
Employee Cost
39.37
39.71
36.84
34.52
35.52
34.66
32.94
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
0.00
0.01
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
40.53
39.72
38.64
40.51
35.46
34.46
33.98
Total Expenditure (Excl Depreciation)
124.47
129.48
121.57
113.86
103.68
103.36
102.44
Operating Profit (PBDIT) excl Other Income
60.06
56.43
45.61
55.25
42.42
51.16
55.38
Other Income
10.28
8.85
8.75
7.69
9.62
6.99
9.50
Operating Profit (PBDIT)
70.34
65.28
54.36
62.94
52.04
58.15
64.88
Interest
0.72
0.76
0.81
0.94
0.93
0.87
0.85
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-15.13
Gross Profit (PBDT)
69.62
64.52
53.55
62.00
51.11
57.28
48.90
Depreciation
10.08
9.62
10.08
8.97
8.90
8.61
9.28
Profit Before Tax
59.54
54.90
43.46
53.02
42.21
48.67
39.61
Tax
14.81
14.46
16.73
14.15
8.82
13.70
9.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
44.73
40.44
26.73
38.88
33.39
34.98
29.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
44.73
40.44
26.73
38.88
33.39
34.98
29.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.41
0.51
0.25
1.23
0.56
0.82
1.56
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
43.33
39.93
26.48
37.65
32.83
34.15
28.31
Equity Capital
22.38
22.38
22.38
22.38
22.37
22.37
22.37
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.87
3.57
2.37
3.36
2.94
3.05
2.53
Diluted Earnings per share
3.87
3.57
2.37
3.36
2.93
3.05
2.53
Operating Profit Margin (Excl OI)
32.55%
30.35%
27.28%
32.67%
29.03%
33.11%
35.09%
Gross Profit Margin
37.73%
34.7%
32.03%
36.66%
34.98%
37.07%
30.98%
PAT Margin
24.24%
21.75%
15.99%
22.99%
22.85%
22.64%
18.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 26.30% vs -7.44% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 31.98% vs -4.59% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 41.58% vs -17.33% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -22.58% vs 24.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Advanced Enzyme With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
184.53
237.05
-52.52
-22.16%
Other Operating Income
0.00
0.00
0.00
Total Operating income
184.53
237.05
-52.52
-22.16%
Raw Material Cost
48.74
113.47
-64.73
-57.05%
Purchase of Finished goods
0.00
25.69
-25.69
-100.00%
(Increase) / Decrease In Stocks
-4.18
-34.72
30.54
87.96%
Employee Cost
39.37
37.45
1.92
5.13%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
40.53
57.32
-16.79
-29.29%
Total Expenditure (Excl Depreciation)
124.47
199.21
-74.74
-37.52%
Operating Profit (PBDIT) excl Other Income
60.06
37.84
22.22
58.72%
Other Income
10.28
2.12
8.16
384.91%
Operating Profit (PBDIT)
70.34
39.96
30.38
76.03%
Interest
0.72
9.58
-8.86
-92.48%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
69.62
30.38
39.24
129.16%
Depreciation
10.08
7.77
2.31
29.73%
Profit Before Tax
59.54
22.60
36.94
163.45%
Tax
14.81
5.78
9.03
156.23%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
44.73
16.82
27.91
165.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
44.73
16.82
27.91
165.93%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
1.41
0.00
1.41
Other related items
0.00
0.00
0.00
Consolidated Net Profit
43.33
16.82
26.51
157.61%
Equity Capital
22.38
10.03
12.35
123.13%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.87
1.68
2.19
130.36%
Diluted Earnings per share
3.87
1.68
2.19
130.36%
Operating Profit Margin (Excl OI)
32.55%
15.96%
0.00
16.59%
Gross Profit Margin
37.73%
12.82%
0.00
24.91%
PAT Margin
24.24%
7.10%
0.00
17.14%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 184.53 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -0.74% vs 11.20% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 26.30% vs -7.44% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 43.33 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 8.51% vs 50.79% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 31.98% vs -4.59% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 60.06 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 6.43% vs 23.72% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 41.58% vs -17.33% in Sep 2024

Quarterly - Interest
Interest 0.72 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -5.26% vs -6.17% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -22.58% vs 24.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.55%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024